The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms

Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries

(2010) H. J. Williams et al.   HUMAN MOLECULAR GENETICS

ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia

(2010) Gary Donohoe et al.   NEUROIMAGE

A Schizophrenia Risk Gene, ZNF804A, Influences Neuroanatomical and Neurocognitive Phenotypes

(2010) Todd Lencz et al.   NEUROPSYCHOPHARMACOLOGY

DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis

(2009) Rainald Mössner et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Replication of association between schizophrenia and ZNF804A in the Irish Case–Control Study of Schizophrenia sample

(2009) B Riley et al.   MOLECULAR PSYCHIATRY

Neue Erkenntnisse zur Genetik der Schizophrenie

(2009) R. Mössner et al.   NERVENARZT

Neural Mechanisms of a Genome-Wide Supported Psychosis Variant

(2009) C. Esslinger et al.   SCIENCE

Common risk genes for affective and schizophrenic psychoses

(2008) Wolfgang Maier   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients

(2008) L. Wang et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Identification of loci associated with schizophrenia by genome-wide association and follow-up

(2008) Michael C O'Donovan et al.   NATURE GENETICS

Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia

(2008) Rainald Mössner et al.   Pharmacogenetics and Genomics